Neue Suche | Kongressdetail
Druckansicht
 
 

Synthetic Lethality Conference, Boston, 2017

evvnt Platform / evvnt
-
31.01.2018 - 01.02.2018  The Colonnade Boston Hotel, 120 Huntington Ave, 02116 Boston MA, USA
Time: 9:00 am to 5:00 pm
 
Kongressthemen
Across 3 content-packed days, the field’s thought leaders from AstraZeneca, Tesaro, Artios, Metabomed, Sierra Oncology and many more will be sharing their insight and lessons learned, collectively enabling the community to:

- Achieve Efficacy across Contexts: Define the key steps required to identify and therapeutically exploit robust synthetic lethal interactions that are conserved across a variety of defined contexts.
Kongressorganizer (PCO)
Hanson Wade
Anmerkungen
Speakers: Graeme Smith - Chief Scientific Officer - Artios Pharma Ltd., J. Carl Barrett - Vice President of Translational science in Oncology - AstraZeneca and many more.
 

Anfragen und Anmeldung:

https://go.evvnt.com/160417-2
Frau Charlotte Harrison
1 212 537 5898
 
Kategorien
Allgemeinmedizin
Sprache
Englisch
Kongressgebühr
USD 4.097,00
(USD 699 - USD 4097)
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
Tel: +44 0207 3230 450
hello@evvnt.com
 
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."

European Health Forum GasteinHilfswerk AustriaAGEM - Arbeitsgemeinschaft Ethnomedizin e. V.Centro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioÖsterreichisches Rotes KreuzCharité International AcademyAnästhesie in Entwicklungsländern e. V.Swiss Tropical and Public Health Institute

Facebook

Sagen Sie uns Ihre professionelle Meinung

Zur Umfrage

Zur Umfrage